The largest database of trusted experimental protocols

4 protocols using a375 atcc crl 1619

1

Culturing Human Skin Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human cutaneous squamous carcinoma cell line SCL-1 was a gift from Prof. Dr. Norbert Fusenig from the German Cancer Research Center (DKFZ, Heidelberg, Germany) (Boukamp et al. 1982 (link)). The human melanoma cell line A375 (ATCC CRL-1619) was obtained from the American Type Culture Collection (ATCC, Virginia, USA). Normal human epidermal keratinocytes (NHEK, C-12001) were ordered from PromoCell (Heidelberg, Germany). SCL-1 and A375 tumor cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, low glucose), supplemented with 10% fetal bovine serum (FBS), streptomycin (100 µg/ml), penicillin (100 U/ml), and GlutaMAX™ (2 mM) at 37 °C in 5% CO2. NHEK were cultured in keratinocyte growth medium (C-20011, PromoCell) including SupplementMix (C-39016), streptomycin (100 µg/ml) and penicillin (100 U/ml) at 37 °C in 5% CO2. Subconfluent cells (70–80% confluence) were used for all experiments, if not otherwise stated. For treatment, SCL-1 and A375 were incubated in high glucose (4500 mg/L) DMEM without FBS, while NHEK were grown in keratinocyte basal medium (C-20211, PromoCell). Gossypol and other substances such as ABT-199, inhibitors, and fluorescent dyes were directly added to the cells at the appropriate concentrations.
+ Open protocol
+ Expand
2

Culturing Human Melanoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human melanoma cells A375 (ATCC® CRL-1619, from primary cutaneous melanoma) and MeWo (ATCC® HTB-65, from lymph node cutaneous melanoma metastasis) were obtained from the American Type Culture Collection (ATCC). 501Mel (from cutaneous melanoma metastasis) were kindly provided by Dr. Poliseno (Oncogenomics Unit, Core Research Laboratory, Istituto Toscano Tumori c/o IFC-CNR, Pisa, Italy).
All cell lines were cultured in RPMI 1640 medium (Euroclone, Milan, Italy) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin (Euroclone, Euroclone, Milan, Italy) in a humidified atmosphere containing 5% CO2 at 37 °C. Cell morphology was examined under light microscopy.
+ Open protocol
+ Expand
3

Melanoma and Keratinocyte Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rutin (Rut), sorbitan monostearate (Span 60) and cholesterol were purchased from Sigma-Aldrich, Merck KgaA, soy lecithin (Lipoid S 75) from Lipoid GmbH (Ludwigshafen, Germany) and absolute ethanol from Merck (Darmstadt, Germany).
The human melanoma cell line—A375 (ATCC® CRL-1619™) was acquired from American Type Culture Collection (ATCC) and the immortalized human keratinocytes—HaCaT (HaCaT-300493) from CLS Cell Lines Service GmbH. The specific cell culture medium—Dulbecco’s modified Eagle’s medium-high glucose (DMEM), penicillin–streptomycin mixture, phosphate saline buffer (PBS), trypsin-EDTA, Trypan blue, dimethyl sulfoxide (DMSO), and alamarBlue (resazurin) were provided by Sigma-Aldrich, Merck KgaA. The fetal calf serum (FCS) and Hoechst 33342 reagent (Invitrogen) were acquired from Thermo Fisher Scientific, Inc., Waltham, MA, USA.
+ Open protocol
+ Expand
4

Culturing Melanoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human melanoma cancer cell line A375 (ATCC® CRL-1619) was obtained from American Type Culture Collection (ATCC). A875, HFF-1, and HSAS3 cell lines were purchased from the National Laboratory Cell Resource (NICR). Cells were maintained in a 37°C incubator with 5% CO2, cultured in DMEM medium (Corning, USA) supplemented with 10% fetal bovine serum (FBS) (Gibco, 10099–141) and 1% penicillin-streptomycin (Gibco,15070063). Cells were passaged with trypsinization every 3 days.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!